3Kortesuo P,Ahola M,Karlesson S,et al.Silica xerogel as an implantable carrier for controlled drug delivery- evaluation of drug distribution and tissue effects after implantation[J].Biomaterials,2000,21(2): 193.
4Netz DJ,Sepulveda P,Pandolfelli VC,et al.Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system[J].Int J Pharm,2001, 213: 117.
5Hurley L,Andersen BR.Biodegradable implants from poly- (alphahydroxy acid)polymers for isoniazid deliv- ery[J].Int J Tuberc Lung Dis,1999,3(11): 1 015.
6Domb AJ,Israel ZH,Elmalak O,et al.Preparation and characterization of carmustine loaded poly anhydride wafers for treating brain tumors[J].Pharm Res,1999,16(5): 762.
7Ailababidi S,Shahj C.Kinetics and mechanism of release from glyceryl monosteanate- based implants: evaluation of release in a gel simulating in vivo implantation[J].Journal of Pharmaceutical Sciences,1998,87(6): 738.
8Gautier H,Caillon J,Le Ray,et al.Influence of isostatic compression on the stability of vanocomycin loaded with a calcium phosphate- implantable drug delivery device[J].J Biomed Mater Res,2000,52(2): 308.
9Bhardwa JR,Blanchard J.In vitro characterization and in vivo release profile of apoly(D,L- lactide- co- gly- colide)- based implant delivery system for the a- MSH analog Melanotan- I[J].International Journal of Pharmaceutics,1998,120: 109.
10Dittrich M,Solich P,Opletal L,et al.20- hydroxyecdy- sone release from biodegradable devices the effect of size and shape[J].Drug Dev Ind Pharm,2000,26(12): 1 285.
